Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Aprepitant: a novel neurokinin-1 receptor/substance P antagonist as antipruritic therapy in cutaneous T-cell lymphoma.

× No keyword cloud information.

6 in total

1. Aprepitant for the Treatment of Pruritus in Sézary Syndrome: A Randomized Crossover Clinical Trial.

Authors: John A Zic; Brittany T Straka; Laura Y McGirt; Hui Nian; Chang Yu; Nancy J Brown
Journal: JAMA Dermatol Date: 2018-10-01 Impact factor: 10.282

2. Aprepitant for refractory cutaneous T-cell lymphoma-associated pruritus: 4 cases and a review of the literature.

Authors: Johanna S Song; Marianne Tawa; Nicole G Chau; Thomas S Kupper; Nicole R LeBoeuf
Journal: BMC Cancer Date: 2017-03-16 Impact factor: 4.430

Review 3. NK-1 Receptor Antagonists and Pruritus: Review of Current Literature.

Authors: Marcelina Pojawa-Gołąb; Kamila Jaworecka; Adam Reich
Journal: Dermatol Ther (Heidelb) Date: 2019-06-12

4. Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial.

Authors: Bruno Vincenzi; Mike Trower; Ajay Duggal; Pamela Guglielmini; Peter Harris; David Jackson; Mario E Lacouture; Emiliangelo Ratti; Giuseppe Tonini; Andrew Wood; Sonja Ständer
Journal: BMJ Open Date: 2020-02-06 Impact factor: 2.692

Review 5. Aprepitant for the Treatment of Chronic Refractory Pruritus.

Authors: Alice He; Jihad M Alhariri; Ronald J Sweren; Madan M Kwatra; Shawn G Kwatra
Journal: Biomed Res Int Date: 2017-09-19 Impact factor: 3.411

Review 6. Pruritus: A Sensory Symptom Generated in Cutaneous Immuno-Neuronal Crosstalk.

Authors: Attila Gábor Szöllősi; Attila Oláh; Erika Lisztes; Zoltán Griger; Balázs István Tóth
Journal: Front Pharmacol Date: 2022-03-07 Impact factor: 5.810

6 in total